Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Clinical Impact ◽

Wild Type ◽

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Annals of Oncology ◽

10.1093/annonc/mdw332.20 ◽

2016 ◽

Vol 27 ◽

pp. iv9

Author(s):

M. Bonomi ◽

L. Bonomi ◽

M.G. Sauta ◽

A.C. Bettini ◽

M. Squadroni ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.114.215418 ◽

2014 ◽

Vol 351 (2) ◽

pp. 352-358 ◽

Cited By ~ 18

Author(s):

Ting-Ting Chao ◽

Cheng-Yi Wang ◽

Chih-Cheng Lai ◽

Yen-Lin Chen ◽

Yi-Ting Tsai ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cell Lung Cancer ◽

Growth Factor Receptor ◽

Wild Type ◽

Epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

Current Opinion in Oncology ◽

10.1097/cco.0000000000000495 ◽

2019 ◽

Vol 31 (1) ◽

pp. 1-7 ◽

Cited By ~ 9

Author(s):

Julia Roeper ◽

Frank Griesinger

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3464-9 ◽

2017 ◽

Vol 80 (6) ◽

pp. 1179-1187 ◽

Cited By ~ 7

Author(s):

Kaiyan Chen ◽

Xiaoqing Yu ◽

Haiyang Wang ◽

Zhiyu Huang ◽

Yanjun Xu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Gastrointestinal toxicities of first and second-generation small molecule human epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

Current Opinion in Supportive and Palliative Care ◽

10.1097/spc.0000000000000210 ◽

2016 ◽

Vol 10 (2) ◽

pp. 152-156 ◽

Cited By ~ 6

Author(s):

Ysabella Z.A. Van Sebille ◽

Rachel J. Gibson ◽

Hannah R. Wardill ◽

Joanne M. Bowen

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

First And Second Generation ◽

Correction to “TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway”

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.117.215418err ◽

2017 ◽

Vol 364 (1) ◽

pp. 26-27

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cell Lung Cancer ◽

Growth Factor Receptor ◽

Wild Type ◽

Oncogenic drivers in nonsmall cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Indian Journal of Cancer ◽

10.4103/ijc.ijc_505_17 ◽

2017 ◽

Vol 54 (5) ◽

pp. 1 ◽

Cited By ~ 2

Author(s):

A Pathak ◽

S Rajappa ◽

A Gore

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

Current Opinion in Oncology ◽

10.1097/cco.0000000000000260 ◽

2016 ◽

Vol 28 (2) ◽

pp. 115-121 ◽

Cited By ~ 13

Author(s):

Robert Pirker

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Third Generation ◽

Epidermal Growth ◽

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

Investigational New Drugs ◽

10.1007/s10637-014-0146-x ◽

2014 ◽

Vol 32 (6) ◽

pp. 1311-1315 ◽

Cited By ~ 16

Author(s):

Hyun Sun Woo ◽

Hee Kyung Ahn ◽

Ha Yeon Lee ◽

Inkeun Park ◽

Young Saing Kim ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Exon 20

A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor (EGFR) mutation responds to EGFR tyrosine kinase inhibitors

Journal of Thoracic Disease ◽

10.21037/jtd.2018.09.101 ◽

2018 ◽

Vol 10 (10) ◽

pp. E739-E743

Author(s):

Yong Zhang ◽

Ling Ye ◽

Huijun Zhang ◽

Xuehua Chen ◽

Haiying Ji ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽